Andy Chen

Stock Analyst at Wolfe Research

(4.38)
# 386
Out of 5,033 analysts
41
Total ratings
53.85%
Success rate
25.85%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Andy Chen

Akero Therapeutics
Oct 10, 2025
Downgrades: Peer Perform
Price Target: n/a
Current: $53.91
Upside: -
89bio
Sep 19, 2025
Downgrades: Peer Perform
Price Target: n/a
Current: $14.80
Upside: -
Alnylam Pharmaceuticals
Aug 4, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $491.22
Upside: -
Vera Therapeutics
Aug 4, 2025
Downgrades: Peer Perform
Price Target: n/a
Current: $30.20
Upside: -
BridgeBio Pharma
Jun 17, 2025
Initiates: Outperform
Price Target: $49
Current: $56.26
Upside: -12.90%
Sarepta Therapeutics
Jun 17, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $23.05
Upside: -
Avidity Biosciences
Jun 17, 2025
Initiates: Outperform
Price Target: $55
Current: $49.01
Upside: +12.22%
MoonLake Immunotherapeutics
May 19, 2025
Upgrades: Outperform
Price Target: $61
Current: $9.36
Upside: +552.06%
Intellia Therapeutics
Apr 21, 2025
Upgrades: Outperform
Price Target: $21
Current: $27.98
Upside: -24.95%
AnaptysBio
Feb 4, 2025
Initiates: Outperform
Price Target: n/a
Current: $35.27
Upside: -
Initiates: Peer Perform
Price Target: n/a
Current: $42.45
Upside: -
Initiates: Outperform
Price Target: $20
Current: $27.48
Upside: -27.22%
Initiates: Outperform
Price Target: $19
Current: $26.21
Upside: -27.51%
Downgrades: Peer Perform
Price Target: n/a
Current: $19.22
Upside: -
Upgrades: Outperform
Price Target: $697
Current: $849.46
Upside: -17.95%
Initiates: Outperform
Price Target: n/a
Current: $86.17
Upside: -
Downgrades: Peer Perform
Price Target: n/a
Current: $27.67
Upside: -
Upgrades: Outperform
Price Target: $65
Current: $60.50
Upside: +7.44%
Initiates: Outperform
Price Target: n/a
Current: $439.97
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $24.09
Upside: -
Downgrades: Peer Perform
Price Target: n/a
Current: $33.67
Upside: -
Upgrades: Outperform
Price Target: n/a
Current: $73.55
Upside: -
Initiates: Peer Perform
Price Target: n/a
Current: $73.97
Upside: -
Initiates: Outperform
Price Target: $17
Current: $17.74
Upside: -4.17%
Initiates: Outperform
Price Target: n/a
Current: $419.10
Upside: -
Initiates: Outperform
Price Target: $42
Current: $167.91
Upside: -74.99%